Ngf Grafts and Huntingtons Disease

Kordower, Jeffrey H.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of Neurological Disorders and Stroke (NINDS)
• Type: Research Project (R01)
• Project #: 1R01NS035078-01
• Application #: 2274413
• Study Section: Neurology B Subcommittee 2 (NEUB)
• Project Start: 1996-06-01
• Project End: 2001-05-31
• Budget Start: 1996-06-01
• Budget End: 1997-05-31
• Support Year: 1
• Fiscal Year: 1996

Institution

• Name: Rush University Medical Center
• City: Chicago
• State: IL
• Country: United States
• Zip Code: 60612

Publications

McBride, Jodi L; During, Matthew J; Wuu, Joanne et al. (2003) Structural and functional neuroprotection in a rat model of Huntington's disease by viral gene transfer of GDNF. Exp Neurol 181:213-23

Leventhal, L; Sortwell, C E; Hanbury, R et al. (2000) Cyclosporin A protects striatal neurons in vitro and in vivo from 3-nitropropionic acid toxicity. J Comp Neurol 425:471-8

Palfi, S; Leventhal, L; Goetz, C G et al. (2000) Delayed onset of progressive dystonia following subacute 3-nitropropionic acid treatment in Cebus apella monkeys. Mov Disord 15:524-30

Kordower, J H; Chen, E Y; Winkler, C et al. (1997) Grafts of EGF-responsive neural stem cells derived from GFAP-hNGF transgenic mice: trophic and tropic effects in a rodent model of Huntington's disease. J Comp Neurol 387:96-113